1. Agency EM. How to prepare and review a summary of product characteristics. 2019. https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation/product-information/how-prepare-review-summary-product-characteristics. Accessed 17 Mar 2020.
2. European Union Pharmacovigilance Legislation. Directive 2001/83/EC of the European Parliament and of the Council. 2001. https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/directive-2001/83/ec-european-parliament-council-6-november-2001-community-code-relating-medicinal-products-human-use_en.pdf. Accessed 15 Nov 2019.
3. Health Canada. Summary Safety Review—Beta-lactam antibiotics—Assessing the potential risk of severe skin side effects. 2018. https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/health-product-infowatch/health-product-infowatch-october-2018.html. Accessed 24 Oct 2018.
4. Yoshida S, Matsui R, Kikuchi C. What drives adoption of national labels as global reference labels? A case study with the JPI. Ther Innov Regul Sci. 2018;52(6):724–30. https://doi.org/10.1177/2168479018755084.
5. Dunne SS, Dunne CP. What do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs. BMC Med. 2015;13:173. https://doi.org/10.1186/s12916-015-0415-3.